Michel Alvinerie

Estimation of absolute oral bioavailability of moxidectin in dogs using a semi-simultaneous method: influence of lipid co-administration.

M. Alvinerie, P. Toutain, E. Lallemand, 2007, Journal of veterinary pharmacology and therapeutics.

Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle.

A. Lifschitz, G. Virkel, J. Sutra, 1997, Journal of veterinary pharmacology and therapeutics.

A non-invasive and quantitative method for the study of tissue injury caused by intramuscular injection of drugs in horses.

M. Alvinerie, P. Toutain, H. Lefebvre, 1995, Journal of veterinary pharmacology and therapeutics.

Evidence for cytochrome P4501A2-mediated protein covalent binding of thiabendazole and for its passive intestinal transport: use of human and rabbit derived cells.

J. Sutra, P. Galtier, M. Alvinerie, 2000, Chemico-biological interactions.

Identification of human and rabbit cytochromes P450 1A2 as major isoforms involved in thiabendazole 5‐hydroxylation

J. Sutra, P. Galtier, M. Alvinerie, 1998, Fundamental & clinical pharmacology.

The pharmacokinetics of moxidectin after oral and subcutaneous administration to sheep.

J. Sutra, P. Galtier, M. Alvinerie, 1998, Veterinary research.